Cargando…
A comprehensive study on regulatory requirements for development and filing of generic drugs globally
The regulatory requirements of various countries of the world vary from each other. Therefore, it is challenging for the companies to develop a single drug which can be simultaneously submitted in all the countries for approval. The regulatory strategy for product development is essentially to be es...
Autores principales: | Handoo, Shweta, Arora, Vandana, Khera, Deepak, Nandi, Prafulla Kumar, Sahu, Susanta Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3555014/ https://www.ncbi.nlm.nih.gov/pubmed/23373001 http://dx.doi.org/10.4103/2230-973X.104392 |
Ejemplares similares
-
Regulatory filing strategy for generic mesalazine modified release formulations
por: Gupta, Sandeep K.
Publicado: (2011) -
Requirements for generic anti-epileptic medicines: a regulatory perspective
por: Maliepaard, Marc, et al.
Publicado: (2009) -
Regulatory requirements for the registration of generic medicines and format of drug dossiers: procedures in Sri Lanka in comparison with selected regulatory authorities
por: Thambavita, D., et al.
Publicado: (2018) -
Regulatory Solutions to the Problem of High Generic Drug Costs
por: Luo, Jing, et al.
Publicado: (2015) -
Meeting Regulatory Requirements for Drugs with a Narrow Therapeutic Index: Bioequivalence Studies of Generic Once-Daily Tacrolimus
por: Gantar, Kaja, et al.
Publicado: (2020)